Frontiers in Endocrinology (May 2024)

Causal association of immune cells and endometriosis: a Mendelian randomization study

  • Xingyi Fang,
  • Qinghua Deng,
  • Haili Yang,
  • Zhaohua Yan,
  • Zhen Peng,
  • Yuheng Zhao,
  • Tantan Liao,
  • Ziying Tu,
  • Jia Liu,
  • Li Liu,
  • Lin Zou,
  • Honghua He

DOI
https://doi.org/10.3389/fendo.2024.1397670
Journal volume & issue
Vol. 15

Abstract

Read online

ObjectiveTo investigate the causal effect of immune cells on endometriosis (EMS), we performed a Mendelian randomization analysis.MethodsMendelian randomization (MR) uses genetic variants as instrumental variables to investigate the causal effects of exposures on outcomes in observational data. In this study, we conducted a thorough two-sample MR analysis to investigate the causal relationship between 731 immune cells and endometriosis. We used complementary Mendelian randomization (MR) methods, including weighted median estimator (WME) and inverse variance weighted (IVW), and performed sensitivity analyses to assess the robustness of our results.ResultsFour immune phenotypes have been found to be significantly associated with the risk of developing EMS: B cell %lymphocyte (WME: OR: 1.074, p = 0.027 and IVW: OR: 1.058, p = 0.008), CD14 on Mo MDSC (WME: OR: 1.056, p =0.021 and IVW: OR: 1.047, p = 0.021), CD14+ CD16− monocyte %monocyte (WME: OR: 0.947, p = 0.024 and IVW: OR: 0.958, p = 0.011), CD25 on unsw mem (WME: OR: 1.055, p = 0.030 and IVW: OR: 1.048, p = 0.003). Sensitivity analyses confirmed the main findings, demonstrating consistency across analyses.ConclusionsOur MR analysis provides compelling evidence for a direct causal link between immune cells and EMS, thereby advancing our understanding of the disease. It also provides new avenues and opportunities for the development of immunomodulatory therapeutic strategies in the future.

Keywords